Kiribati vs Myanmar: Cause of death, by non-communicable diseases, ages 0-4, female
Kiribati
13.3%
in 2021
Myanmar
13.2%
in 2021
Kiribati rank
135th
Myanmar rank
136th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Kiribati
- Myanmar
How they compare
Kiribati currently reports 13.3% against 13.2% in Myanmar, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Kiribati ahead.
Kiribati ranks 135th and Myanmar ranks 136th of 185 countries.
Across the 3 decades both report, Kiribati averaged higher in 2 and Myanmar in 1.
Head to head by decade
| Decade | Kiribati | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.6% | 9.9% | 1.7% | Kiribati |
| 2010s | 15.1% | 13.5% | 1.5% | Kiribati |
| 2020s | 14.1% | 14.5% | 0.3% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Kiribati or Myanmar?
- Kiribati, at 13.3% against 13.2% in Myanmar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Kiribati and Myanmar?
- 0.1%, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and Myanmar?
- 6 years are reported by both, from 2000 to 2021.
- How do Kiribati and Myanmar rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Kiribati ranks 135th and Myanmar ranks 136th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.